Health Research of Oklahoma | Oklahoma City, OK
Site insights
Top conditions
Top treatments
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
The purpose of this study is to compare the safety and efficacy of risankizumab versus placebo in participants with moderately to severely active pso...
The purpose of this study is to evaluate the safety and efficacy of risankizumab in adults with moderately to severely active psoriatic arthritis (Ps...
The study objectives of Period 1 are to compare the efficacy, safety, and tolerability of upadacitinib 15 mg once daily (QD) and 30 mg QD versus plac...
This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...
The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoi...
This protocol includes 2 standalone studies with randomization, data collection, analysis and reporting conducted independently.The main objectives o...
The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) and inadequate re...
The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the...
The RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderat...
Trial sponsors
Clinical trials
Research sites
Resources
Legal